GSK Says Individual Plaintiff in Latest Zantac Case Drops Claim
Wall Street Journal
GSK said the trial was scheduled to start on Monday in Illinois, adding that it didn’t reach a settlement and didn’t make any payments in exchange for the voluntary case dismissal.